1. Home
  2. BCYC vs DNN Comparison

BCYC vs DNN Comparison

Compare BCYC & DNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • DNN
  • Stock Information
  • Founded
  • BCYC 2009
  • DNN 1936
  • Country
  • BCYC United Kingdom
  • DNN Canada
  • Employees
  • BCYC N/A
  • DNN N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • DNN Other Metals and Minerals
  • Sector
  • BCYC Health Care
  • DNN Basic Materials
  • Exchange
  • BCYC Nasdaq
  • DNN Nasdaq
  • Market Cap
  • BCYC 1.7B
  • DNN 1.8B
  • IPO Year
  • BCYC 2019
  • DNN 1997
  • Fundamental
  • Price
  • BCYC $15.59
  • DNN $2.04
  • Analyst Decision
  • BCYC Buy
  • DNN Strong Buy
  • Analyst Count
  • BCYC 9
  • DNN 2
  • Target Price
  • BCYC $36.00
  • DNN $3.00
  • AVG Volume (30 Days)
  • BCYC 880.7K
  • DNN 20.7M
  • Earning Date
  • BCYC 10-31-2024
  • DNN 11-07-2024
  • Dividend Yield
  • BCYC N/A
  • DNN N/A
  • EPS Growth
  • BCYC N/A
  • DNN N/A
  • EPS
  • BCYC N/A
  • DNN N/A
  • Revenue
  • BCYC $36,898,000.00
  • DNN $2,920,167.00
  • Revenue This Year
  • BCYC $40.52
  • DNN $272.08
  • Revenue Next Year
  • BCYC N/A
  • DNN $77.80
  • P/E Ratio
  • BCYC N/A
  • DNN N/A
  • Revenue Growth
  • BCYC 48.60
  • DNN N/A
  • 52 Week Low
  • BCYC $12.17
  • DNN $1.40
  • 52 Week High
  • BCYC $28.67
  • DNN $2.47
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 37.83
  • DNN 40.34
  • Support Level
  • BCYC $12.17
  • DNN $1.97
  • Resistance Level
  • BCYC $21.50
  • DNN $2.26
  • Average True Range (ATR)
  • BCYC 1.36
  • DNN 0.11
  • MACD
  • BCYC -0.36
  • DNN -0.04
  • Stochastic Oscillator
  • BCYC 49.67
  • DNN 14.96

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

About DNN Denison Mines Corp (Canada)

Denison Mines Corp is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. The company has an effective 95% interest in its flagship Wheeler River Uranium Project, which is the largest undeveloped uranium project in the infrastructure-rich eastern portion of the Athabasca Basin region of northern Saskatchewan. The company is also engaged in mine decommissioning and environmental services through its Closed Mines group, which manages its Elliot Lake reclamation projects and provides third-party post-closure mine care and maintenance services.

Share on Social Networks: